Shares in Genmab A/S were off by more than 7 percent during trading Tuesday following an interim update on a Phase III pivotal study of zalutumumab (HuMax-EGFr) in head and neck cancer. (BioWorld International)

No Abstract BioWorld International CorrespondentThe Oslo Cancer Cluster, a Norwegian industry and research cluster focused on oncology, is seeking a €300 million (US$418 million) government bailout to help the country's fledgling biotechnology sector to weather the international financial crisis.

Shares in Intercell AG rose by more than 8.5 percent Monday on news that the company's lead product, a vaccine against Japanese Encephalitis virus (JEV), received a positive opinion from the Committee on Human Medicinal Products, of the European Medicines Agency. (BioWorld International)